Obstetrics & Gynecology Doctors in Klamath Falls, OR Accepting Medicare

8 Obstetrics & Gynecology doctors found. Showing 1 - 8

Dr. Mark A Parra, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn Street, Klamath Falls, OR 97601 Phone: 541-205-6890    Fax: 541-205-6899

Laura A Matlock, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn St Ste 1, Klamath Falls, OR 97601 Phone: 541-205-6890    Fax: 541-205-6899

Dr. Arielle A Metz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn Street, Suite 1, Klamath Falls, OR 97601 Phone: 541-205-6890

Dr. Luana Jennifer Hossain, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn St Ste 1, Klamath Falls, OR 97601 Phone: 541-205-6890

Gregory K Sindmack, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2686 Campus Drive, Klamath Falls, OR 97601 Phone: 541-882-8829    Fax: 541-882-8086

Christopher Barton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2850 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-274-8610    Fax: 541-884-1151

Chelsea Patricia Crabtree, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn St, Klamath Falls, OR 97601 Phone: 541-205-6890

Dr. Martin L. Meinig, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2640 Biehn Street, Suite 1, Klamath Falls, OR 97601 Phone: 541-205-6890

News Archive

Gold nanoparticles with slight positive charge work collectively to unravel DNA's double helix

New research from North Carolina State University finds that gold nanoparticles with a slight positive charge work collectively to unravel DNA's double helix. This finding has ramifications for gene therapy research and the emerging field of DNA-based electronics.

FDA grants Impax final approval for generic Allegra-D ANDA

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.

Survey finds most hospitals, birthing centers do not routinely screen for congenital heart defects

Only about two out of every 100 babies (1.8 percent) were screened at birth for congenital heart defects (CHDs) because the hospital or birthing center where the baby was born routinely screens all newborns for CHDs - the number-one birth defect and leading killer of infants and newborns. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.

New regulations could improve vets' access to care for some traumatic brain injuries

The Department of Veterans Affairs has approved new regulations to make it easier for veterans to receive health care and compensation for certain illnesses, including Parkinsonism, dementia, and depression, which have been linked to traumatic brain injury

Read more Medical News

› Verified 5 days ago